glp-1 news today october 23 2025 The Impact of GLP-1 Drugs on the Agri-Food System Rhode Island considers ending Medicaid

NAD IV therapy NAD (nicotinamide adenine dinucleotide) is a molecule that is involved in several important metabolic processes in the body

It can lead to a number of problems, including abdominal pain, diarrhea, and weight loss

It is a white, crystalline, hygroscopic powder with a slightly bitter taste

,

Patients should seek urgent medical attention if they experience: Severe or persistent abdominal pain (possible pancreatitis or gallbladder complication) Signs of dehydration (dizziness, reduced urine output) due to vomiting or diarrhoea Symptoms of hypoglycaemia (shakiness, sweating, confusion) or hyperglycaemia (excessive thirst, frequent urination) Severe headache or visual disturbance (possible raised intracranial pressure) Signs of an allergic reaction (rash, swelling, difficulty breathing) Regular monitoring should include fasting glucose, HbA1c, IGF-1, lipid panels, liver function, and renal function

Not more clinical